These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 32418074)

  • 1. Macrophage activation syndrome in children with Kawasaki disease: diagnostic and therapeutic approaches.
    Han SB; Lee SY
    World J Pediatr; 2020 Dec; 16(6):566-574. PubMed ID: 32418074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage activation syndrome in children with Kawasaki disease: an experience from a tertiary care hospital in northwest India.
    Pilania RK; Jindal AK; Johnson N; Prithvi A; Vignesh P; Suri D; Rawat A; Gupta A; Singh S
    Rheumatology (Oxford); 2021 Jul; 60(7):3413-3419. PubMed ID: 33221920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kawasaki Disease Complicated With Macrophage Activation Syndrome: A Systematic Review.
    García-Pavón S; Yamazaki-Nakashimada MA; Báez M; Borjas-Aguilar KL; Murata C
    J Pediatr Hematol Oncol; 2017 Aug; 39(6):445-451. PubMed ID: 28562511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical features of Kawasaki disease complicated by macrophage activation syndrome: an analysis of 27 cases].
    Wen YN; Chen J; Liu F; Ding Y; Yin W
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Jun; 25(6):572-578. PubMed ID: 37382125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage activation syndrome in the acute phase of Kawasaki disease.
    Latino GA; Manlhiot C; Yeung RS; Chahal N; McCrindle BW
    J Pediatr Hematol Oncol; 2010 Oct; 32(7):527-31. PubMed ID: 20485197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage activation syndrome in Kawasaki disease: more common than we thought?
    Wang W; Gong F; Zhu W; Fu S; Zhang Q
    Semin Arthritis Rheum; 2015 Feb; 44(4):405-10. PubMed ID: 25200945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kawasaki disease shock syndrome complicated with macrophage activation syndrome in a 5-month old boy: A case report.
    Lin Y; Shi L; Deng YJ; Liu Y; Zhang HW
    Medicine (Baltimore); 2019 Jan; 98(4):e14203. PubMed ID: 30681594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and laboratory features, treatment, and outcomes of macrophage activation syndrome in 80 children: a multi-center study in China.
    Zou LX; Zhu Y; Sun L; Ma HH; Yang SR; Zeng HS; Xiao JH; Yu HG; Guo L; Xu YP; Lu MP
    World J Pediatr; 2020 Feb; 16(1):89-98. PubMed ID: 31612427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage activation syndrome in Kawasaki disease.
    Mukherjee D; Pal P; Kundu R; Niyogi P
    Indian Pediatr; 2014 Feb; 51(2):148-9. PubMed ID: 24632699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single center clinical analysis of macrophage activation syndrome complicating juvenile rheumatic diseases.
    Huang S; Liu Y; Yan W; Zhang T; Wang P; Zhu M; Zhang X; Zhou P; Fan Z; Yu H
    Pediatr Rheumatol Online J; 2024 May; 22(1):58. PubMed ID: 38783316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences and similarities of multisystem inflammatory syndrome in children, Kawasaki disease and macrophage activating syndrome due to systemic juvenile idiopathic arthritis: a comparative study.
    Otar Yener G; Paç Kısaarslan A; Ulu K; Atalay E; Haşlak F; Özdel S; Bozkaya Yücel B; Gezgin Yıldırım D; Çakmak F; Öztürk K; Çakan M; Balık Z; Hasbal Akkuş C; Yıldız M; Erat T; Çetin BŞ; Yılmaz M; Bağlan E; Laçinel Gürlevik S; Atasayan V; Karadağ ŞG; Adrovic A; Çağlayan Ş; Tanatar A; Demirkan FG; Coşkuner T; Akgün Ö; Kasap Cüceoğlu M; Kavrul Kayaalp G; Şahin S; Başaran Ö; Demir F; Barut K; Çiftel M; Gürses D; Baykan A; Özsürekçi Y; Karagöz T; Sönmez HE; Bilginer Y; Aktay Ayaz N; Aydoğ Ö; Yüksel S; Sözeri B; Kasapçopur Ö; Özen S
    Rheumatol Int; 2022 May; 42(5):879-889. PubMed ID: 34491393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children.
    Lee PY; Day-Lewis M; Henderson LA; Friedman KG; Lo J; Roberts JE; Lo MS; Platt CD; Chou J; Hoyt KJ; Baker AL; Banzon TM; Chang MH; Cohen E; de Ferranti SD; Dionne A; Habiballah S; Halyabar O; Hausmann JS; Hazen MM; Janssen E; Meidan E; Nelson RW; Nguyen AA; Sundel RP; Dedeoglu F; Nigrovic PA; Newburger JW; Son MBF
    J Clin Invest; 2020 Nov; 130(11):5942-5950. PubMed ID: 32701511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Macrophage activation syndrome and Kawasaki disease: Four new cases].
    Dumont B; Jeannoel P; Trapes L; Rolland E; Gay C; Stephan JL
    Arch Pediatr; 2017 Jul; 24(7):640-646. PubMed ID: 28583781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High dose Anakinra for treatment of severe neonatal Kawasaki disease: a case report.
    Shafferman A; Birmingham JD; Cron RQ
    Pediatr Rheumatol Online J; 2014; 12():26. PubMed ID: 25045337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?
    Demirkol D; Yildizdas D; Bayrakci B; Karapinar B; Kendirli T; Koroglu TF; Dursun O; Erkek N; Gedik H; Citak A; Kesici S; Karabocuoglu M; Carcillo JA;
    Crit Care; 2012 Dec; 16(2):R52. PubMed ID: 22715953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Infliximab in the Treatment of Macrophage Activation Syndrome Complicating Kawasaki Disease.
    Rivera-Rodriguez L; Pardo-Díaz E; Moreno-Espinosa S; Scheffler-Mendoza S; Ruiz-Ontiveros MA; Garrido-García LM; Iglesias-Amaya A; Yamazaki-Nakashimada MA
    J Pediatr Hematol Oncol; 2021 Apr; 43(3):e448-e451. PubMed ID: 32079989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristic elevation of soluble TNF receptor II : I ratio in macrophage activation syndrome with systemic juvenile idiopathic arthritis.
    Shimizu M; Inoue N; Mizuta M; Nakagishi Y; Yachie A
    Clin Exp Immunol; 2018 Mar; 191(3):349-355. PubMed ID: 28815559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose anakinra as treatment for macrophage activation syndrome caused by refractory Kawasaki disease in an infant.
    Lind-Holst M; Hartling UB; Christensen AE
    BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31383678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage Activation Syndrome.
    Sen ES; Clarke SL; Ramanan AV
    Indian J Pediatr; 2016 Mar; 83(3):248-53. PubMed ID: 26400031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult macrophage activation syndrome-haemophagocytic lymphohistiocytosis: 'of plasma exchange and immunosuppressive escalation strategies' - a single centre reflection.
    Lorenz G; Schul L; Schraml F; Riedhammer KM; Einwächter H; Verbeek M; Slotta-Huspenina J; Schmaderer C; Küchle C; Heemann U; Moog P
    Lupus; 2020 Mar; 29(3):324-333. PubMed ID: 32013725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.